JOP20180089A1 - طرق علاج سرطانات الأطفال - Google Patents

طرق علاج سرطانات الأطفال

Info

Publication number
JOP20180089A1
JOP20180089A1 JOP/2018/0089A JOP20180089A JOP20180089A1 JO P20180089 A1 JOP20180089 A1 JO P20180089A1 JO P20180089 A JOP20180089 A JO P20180089A JO P20180089 A1 JOP20180089 A1 JO P20180089A1
Authority
JO
Jordan
Prior art keywords
methods
pediatric cancers
treating pediatric
treating
subject
Prior art date
Application number
JOP/2018/0089A
Other languages
English (en)
Inventor
Michael Cox
Nisha Nanda
Steven A Smith
Mark Reynolds
Original Assignee
Loxo Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loxo Oncology Inc filed Critical Loxo Oncology Inc
Priority to JOP/2018/0089A priority Critical patent/JOP20180089A1/ar
Publication of JOP20180089A1 publication Critical patent/JOP20180089A1/ar

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JOP/2018/0089A 2018-10-02 2018-10-02 طرق علاج سرطانات الأطفال JOP20180089A1 (ar)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JOP/2018/0089A JOP20180089A1 (ar) 2018-10-02 2018-10-02 طرق علاج سرطانات الأطفال

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JOP/2018/0089A JOP20180089A1 (ar) 2018-10-02 2018-10-02 طرق علاج سرطانات الأطفال

Publications (1)

Publication Number Publication Date
JOP20180089A1 true JOP20180089A1 (ar) 2020-04-02

Family

ID=75469096

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2018/0089A JOP20180089A1 (ar) 2018-10-02 2018-10-02 طرق علاج سرطانات الأطفال

Country Status (1)

Country Link
JO (1) JOP20180089A1 (ar)

Similar Documents

Publication Publication Date Title
PH12018502134A1 (en) Methods of treating pediatric cancers
PH12018502124A1 (en) Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
PH12021550809A1 (en) Crystalline form of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
MX2023008453A (es) Metodos de tratamiento para el abuso de sustancias.
MX2014010590A (es) Terapia de combinacion para trastornos proliferativos.
MX2022015695A (es) Medicina de camptotecina con alta unidad de conexion hidrofila y conjugado de la misma.
MX2018001659A (es) Terapia de combinacion que usa irinotecan liposomal y un inhibidor de poli(adp-ribosa) polimerasa (parp) para el tratamiento del cancer.
WO2020102804A3 (en) Pharmaceutical combination for treatment of cancer
MX2019013643A (es) Terapia de combinacion de 7-bencil-10-(2-metilbencil)-2,6,7,8,9,10 -hexahidroimidazo[1,2-a]pirido [4,3-d]pirimidin-5(3h)-ona.
MX2021002321A (es) Nuevos metodos.
MX2020008680A (es) Terapia de combinacion con apilimod y agentes glutamatergicos.
PH12018502422A1 (en) Nanoliposomal irinotecan for use in treating small cell lung cancer
WO2018102687A3 (en) Combination therapy for treating cancer
WO2018102261A3 (en) Boronic derivatives hydroxamates as anticancer agents
MX2021002322A (es) Nuevos metodos.
MX2022006566A (es) Tratamientos conjuntos para tratamiento de cancer de mama.
PH12021551235A1 (en) Elacestrant in combination with abemaciclib in women with breast cancer
MX2021011289A (es) Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas.
MX2019004602A (es) Agentes anti-proliferativos para tratar pah.
JOP20180089A1 (ar) طرق علاج سرطانات الأطفال
MX2022000729A (es) Terapia de combinacion para el tratamiento del cancer.
JOP20210221A1 (ar) علاجات مشتركة لاستخدامها في علاج السرطان
MX2021007324A (es) Terapia oral con acido 6,8-bis-benciltio-octanoico.
JOP20180088B1 (ar) صيغ سائلة من (s)-n-(5-((r)-2-(2، 5-داي فلورو فينيل)-بيروليدين-1-يل)-بيرازولو[1، 5-a] بيريميدين-3-يل)-3-هيدروكسي بيروليدين-1-كربوكساميد
PH12015500915A1 (en) Bremelanotide therapy for female sexual dysfunction